<?xml version="1.0" encoding="UTF-8"?>
<p id="par0130">The collection of upper respiratory nasopharyngeal (NP) swabs for the diagnostic tests has been recommended (
 <xref rid="bib0055" ref-type="bibr">Centers for Disease Prevention and Control (CDC, 2020</xref>). The Charit√© algorithm has two steps: the first step involves two reverse transcriptase PCR (RT-PCR) assays for genes encoding E protein and RNA- dependent RNA polymerase (RdRp) of Sarbecovirus subfamily; if both the tests are positive, the sample proceeds to the second step, wherein it is tested for SARS-CoV-2 specific RdRp by RT-PCR (
 <xref rid="bib0285" ref-type="bibr">Loeffelholz and Tang, 2020</xref>). However, these methods are cost-intensive, and thus cheaper alternatives have been developed to track the symptoms of COVID-19 such as smart-phone surveillance (
 <xref rid="bib0145" ref-type="bibr">Dorigatti et al., 2020</xref>). Imaging techniques are also used as a diagnostic method in COVID-19, including chest CT scans, which have been commonly used to detect lung abnormalities caused by SARS-CoV-2 infection (
 <xref rid="bib0405" ref-type="bibr">Shi et al., 2020</xref>; 
 <xref rid="bib0500" ref-type="bibr">Xu et al., 2020a</xref>, 
 <xref rid="bib0505" ref-type="bibr">b</xref>).
</p>
